Tranexamic Acid (Akorn, Inc.)
Welcome to the PulseAid listing for the Tranexamic Acid drug offered from Akorn, Inc.. This Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Tranexamic Acid |
SUBSTANCE NAME: | TRANEXAMIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-06-09 |
END MARKETING DATE: | 0000-00-00 |
Tranexamic Acid HUMAN PRESCRIPTION DRUG Details:
Item Description | Tranexamic Acid from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/mL) |
START MARKETING DATE: | 2016-06-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-017_a6c9457c-6de9-42cd-9a7c-58e9ffaa2298 |
PRODUCT NDC: | 17478-017 |
APPLICATION NUMBER: | ANDA206634 |
Other TRANEXAMIC ACID Pharmaceutical Manufacturers / Labelers: